Download PDF
Facial Plast Surg 2020; 36(04): 462-477
DOI: 10.1055/s-0040-1713823
Original Article

Complications in Lower Face Rejuvenation: Avoiding, Minimizing, Recognizing, Dealing with Them, and Helping the Patient through the Process of Fixing the Problems

William H. Truswell
1   Aesthetic Laser and Cosmetic Surgery Center, Northampton, Massachusetts
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

All surgical and minimally invasive procedures carry a risk of complications. It is imperative that the facial plastic surgeon and his/her staff are well educated in recognizing and managing all the possible problems that could arise. They must also be ready and able to deal with and correct any problem. The patient undergoing surgery or a procedure also needs to be informed of all possible sequelae and complications. Sequelae will happen after almost all procedures. These include soreness, swelling, bruising, and so on. If the patients understand that these are to be expected, they will be less likely to be overly concerned about them. They also must be educated about all the possible complications. They should be told that while complications are very rare, they could nevertheless happen. If a problem should arise, the surgeon and his/her staff should correct it and see that the patient receives the best care possible. This article examines the complications that could occur after rejuvenation surgery and minimally invasive procedures of the lower face and neck, what measures can be undertaken to reduce the risks, and how to recognize and manage them.

Keywords

hematoma - infection - nerve injury - skin loss - hair loss


Publication History

Article published online:
31 August 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers
333 Seventh Avenue, New York, NY 10001, USA.

 

  • References

  • 1 Sorensen EP, Urman C. Cosmetic complications: rare and serious events following botulinum toxin and soft tissue filler administration. J Drugs Dermatol 2015; 14 (05) 486-491
    PubMedGoogle Scholar
  • 2 Scheinfeld N. The use of apraclonidine eyedrops to treat ptosis after the administration of botulinum toxin to the upper face. Dermatol Online J 2005; 11 (01) 9
    CrossrefPubMedGoogle Scholar
  • 3 Carruthers J, Carruthers A. Complications of botulinum toxin type A. Facial Plast Surg Clin North Am 2007; 15 (01) 51-54 , vi
    CrossrefPubMedGoogle Scholar
  • 4 Rayess HM, Svider PF, Hanba C. , et al. A cross sectional analysis of adverse events and litigation for injectable fillers. JAMA Facial Plast Surg 2018; 20 (03) 207-214
    CrossrefPubMedGoogle Scholar
  • 5 Daines SM, Williams EF. Complications associated with injectable soft-tissue fillers: a 5-year retrospective review. JAMA Facial Plast Surg 2013; 15 (03) 226-231
    CrossrefPubMedGoogle Scholar
  • 6 Kim JH, Ahn DK, Jeong HS, Suh IS. Treatment algorithm of complications after filler injection: based on wound healing process. J Korean Med Sci 2014; 29 (Suppl. 03) S176-S182
    CrossrefPubMedGoogle Scholar
  • 7 Lam SM, Azizzadeh B, Graivier M. Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring. Plast Reconstr Surg 2006; 118 (03) 55S-63S
    CrossrefPubMedGoogle Scholar
  • 8 Lambros V. The use of hyaluronidase to reverse the effects of hyaluronic acid filler. Plast Reconstr Surg 2004; 114 (01) 277
    CrossrefPubMedGoogle Scholar
  • 9 Sclafani AP, Fagien S. Treatment of injectable soft tissue filler complications. Dermatol Surg 2009; 35 (Suppl. 02) 1672-1680
    CrossrefPubMedGoogle Scholar
  • 10 Carle MV, Roe R, Novack R, Boyer DS. Cosmetic facial fillers and severe vision loss. JAMA Ophthalmol 2014; 132 (05) 637-639
    CrossrefPubMedGoogle Scholar
  • 11 Park SH, Sun HJ, Choi KS. Sudden unilateral visual loss after autologous fat injection into the nasolabial fold. Clin Ophthalmol 2008; 2 (03) 679-683
    PubMedGoogle Scholar
  • 12 Whiteman DW, Rosen DA, Pinkerton RM. Retinal and choroidal microvascular embolism after intranasal corticosteroid injection. Am J Ophthalmol 1980; 89 (06) 851-853
    CrossrefPubMedGoogle Scholar
  • 13 Alijotas-Reig J, Garcia-Gimenez V, Vilardell-Tarres M. Late-onset immune-mediated adverse effects after poly-L-lactic acid injection in non-HIV patients: clinical findings and long-term follow-up. Dermatology 2009; 219 (04) 303-308
    CrossrefPubMedGoogle Scholar
  • 14 Truswell WH, Fox AJ. Skin resurfacing and chemical peels. In: Sataloff RT. , ed. Sataloff's Comprehensive Textbook of Otolaryngology: Head and Neck Surgery: Facial Plastic and Reconstructive Surgery. Vol. 3. New Delhi, India: Jaypee Brothers Medical Publishers Ltd.; 2016: 365-384
    Google Scholar
  • 15 Brody Hed. History of chemical peels. Chemical Peeling. St Louis, MO: Mosby-Yearbook; 1992: 1-5
    Google Scholar
  • 16 Mackee GM, Karp FL. The treatment of post-acne scars with phenol. Br J Dermatol 1952; 64 (12) 456-459
    CrossrefPubMedGoogle Scholar
  • 17 Hetter GP. An examination of the phenol-croton oil peel: part I. Dissecting the formula. Plast Reconstr Surg 2000; 105 (01) 227-239 , discussion 249–251
    CrossrefPubMedGoogle Scholar
  • 18 Hetter GP. An examination of the phenol-croton oil peel: part III. The plastic surgeons' role. Plast Reconstr Surg 2000; 105 (02) 752-763
    CrossrefPubMedGoogle Scholar
  • 19 Hetter GP. An examination of the phenol-croton oil peel: part II. The lay peelers and their croton oil formulas. Plast Reconstr Surg 2000; 105 (01) 240-248 , discussion 249–251
    CrossrefPubMedGoogle Scholar
  • 20 Hetter GP. An examination of the phenol-croton oil peel: part IV. Face peel results with different concentrations of phenol and croton oil. Plast Reconstr Surg 2000; 105 (03) 1061-1083 , discussion 1084–1087
    CrossrefPubMedGoogle Scholar
  • 21 Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124 (06) 869-871
    CrossrefPubMedGoogle Scholar
  • 22 Glogau RJ. Chemical peeling and aging skin. J Geriatr Dermatol 1994; 2: 30-35
    PubMedGoogle Scholar
  • 23 Duplechain JK. Complications in laser resurfacing: avoidance recognition and treatment. In: Truswell WH. , ed. Lasers and Light, Peels and Abrasions – Applications and Treatments. New York, NY: Thieme; 2016: 149-156
    Google Scholar
  • 24 Alster TS, Nanni CA. Famciclovir prophylaxis of herpes simplex virus reactivation after laser skin resurfacing. Dermatol Surg 1999; 25 (03) 242-246
    CrossrefPubMedGoogle Scholar
  • 25 Graber EM, Tanzi EL, Alster TS. Side effects and complications of fractional laser photothermolysis: experience with 961 treatments. Dermatol Surg 2008; 34 (03) 301-305 , discussion 305–307
    PubMedGoogle Scholar
  • 26 Campbell TM, Goldman MP. Adverse events of fractionated carbon dioxide laser: review of 373 treatments. Dermatol Surg 2010; 36 (11) 1645-1650
    CrossrefPubMedGoogle Scholar
  • 27 Metelitsa AI, Alster TS. Fractionated laser skin resurfacing treatment complications: a review. Dermatol Surg 2010; 36 (03) 299-306
    CrossrefPubMedGoogle Scholar
  • 28 Ratner D, Tse Y, Marchell N, Goldman MP, Fitzpatrick RE, Fader DJ. Cutaneous laser resurfacing. J Am Acad Dermatol 1999; 41 (3 Pt 1): 365-389 (PMID: , quiz 390–392)
    CrossrefPubMedGoogle Scholar
  • 29 Fife DJ, Fitzpatrick RE, Zachary CB. Complications of fractional CO2 laser resurfacing: four cases. Lasers Surg Med 2009; 41 (03) 179-184
    CrossrefPubMedGoogle Scholar
  • 30 Weinstein C, Pozner JN, Ramirez OM. Complications of carbon dioxide laser resurfacing and their prevention. Aesthet Surg J 1997; 17 (04) 216-225
    CrossrefPubMedGoogle Scholar
  • 31 Hunzeker CM, Weiss ET, Geronemus RG. Fractionated CO2 laser resurfacing: our experience with more than 2000 treatments. Aesthet Surg J 2009; 29 (04) 317-322
    CrossrefPubMedGoogle Scholar
  • 32 Alster TS, Lupton JR. Treatment of complications of laser skin resurfacing. Arch Facial Plast Surg 2000; 2 (04) 279-284
    CrossrefPubMedGoogle Scholar
  • 33 Tan KL, Kurniawati C, Gold MH. Low risk of postinflammatory hyperpigmentation in skin types 4 and 5 after treatment with fractional CO2 laser device. J Drugs Dermatol 2008; 7 (08) 774-777
    PubMedGoogle Scholar
  • 34 Schwartz RJ, Burns AJ, Rohrich RJ, Barton Jr FE, Byrd HS. Long-term assessment of CO2 facial laser resurfacing: aesthetic results and complications. Plast Reconstr Surg 1999; 103 (02) 592-601
    CrossrefPubMedGoogle Scholar
  • 35 Moyer JS, Baker SR. Complications of rhytidectomy. Facial Plast Surg Clin North Am 2005; 13 (03) 469-478
    CrossrefPubMedGoogle Scholar
  • 36 Truswell Wed. The facelift: a guide for safe, reliable, and reproducible results. In: Surgical Facial Rejuvenation a Roadmap to Safe and Reliable Outcomes. New York; NY: Thieme; 2008: 24-45
    Google Scholar
  • 37 Chaffoo RAK. Complications in facelift surgery: avoidance and management. Facial Plast Surg Clin North Am 2013; 21 (04) 551-558
    CrossrefPubMedGoogle Scholar
  • 38 Truswell WH. Dual-porosity expanded polytetrafluoroethylene soft tissue implant: a new implant for facial soft tissue augmentation. Arch Facial Plast Surg 2002; 4 (02) 92-97
    CrossrefPubMedGoogle Scholar
  • 39 Truswell WH. Using permanent implant materials for cosmetic enhancement of the perioral region. Facial Plast Surg Clin North Am 2007; 15 (04) 433-444 , vi
    CrossrefPubMedGoogle Scholar
  • 40 Adamson PA, Moran ML. Complications of cervicofacial rhytidectomy. Facial Plast Surg Clin North Am 1993; 1: 257-271
    PubMedGoogle Scholar
  • 41 Knuttel R, Torabian SZ, Fung M. Hair loss after rhytidectomy. Dermatol Surg 2004; 30 (07) 1041-1042
    PubMedGoogle Scholar